XML 36 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Investments and Restricted Investments (Tables)
12 Months Ended
Jan. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Instruments
The fair value of the Company’s financial instruments as of January 30, 2021 and February 1, 2020 are as follows:

($000)20202019
Cash and cash equivalents (Level 1)
$4,819,293 $1,351,205 
Investments (Level 2)
$8 $
Restricted cash and cash equivalents (Level 1)
$134,476 $60,205 
Schedule of Fair Value of Assets and Liabilities The fair value measurement for funds with quoted market prices in active markets (Level 1) and for funds without quoted market prices in active markets (Level 2) are as follows:
($000)20202019
Level 1$159,116 $134,440 
Level 2 7,003 
Total$159,116 $141,443